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Protocol
========

1. Growth of Parasites
----------------------

1.  Grow trypomastigote forms of *T. cruzi* Berenice and the β-galactosidase-expressing Tulahuen *T. cruzi* MHOM/CH/00 C4 in murine muscle cell (L6) cultivated in Dulbecco minimal essential medium with 10% FSB, 100 IU/ml penicillin, 100 μg/ml streptomycin, and 250 nM L-glutamin (pH 7.2), 5% CO~2~ at 37 °C. The free-swimming trypomastigotes in the supernatant medium were used to inoculate chicken eggs.

2.  Grow *Leishmania braziliensis (Lb)* LTB300 stock grown in DMEM with 20% FBS. The *Lb* promastigote form in the exponential growth phase was used to inoculate eggs ^9^.

2. Parasite Inoculation in Fertilized Chicken Eggs
--------------------------------------------------

1.  Inoculate a suspension of 100 *T. cruzi* trypomastigotes in 10 μl of culture medium through a 2-mm diameter hole into the egg shell on top of the air chamber of stage X fertile eggs. The invasion and replication of the virulent parasites into the embryo cells are shown in Video S1. The control groups are as follows: a) control chickens; b) mock control eggs receiving 10 μl of culture medium; c) Stage X fertile eggs inoculated with a suspension of 100 *Lb* promastigotes in 10 μl of culture medium. *T. cruzi* and *Lb* belong to the kinetoplastid family. Respectively, these protozoans grow free in the cytoplasm or in parasitophorous vacuole of host cells ^10^.

2.  Seal holes with adhesive tape.

3.  Incubate the *T. cruzi*-infected eggs and mock and uninfected control samples at 37.5 °C and 65% humidity for 21 days.

4.  Keep the chicks that hatch in the incubator for 24 h and thereafter at 32 °C for three weeks.

3. Obtaining Samples for DNA Extraction
---------------------------------------

1.  Peripheral blood mononuclear cells were obtained from chickens: a) hatched from *T. cruzi* inoculated eggs; b) controls; c) mocks receiving 10 μl of culture medium; d) hatched from *Lb* inoculated eggs; White blood cells from chickens are processed for DNA extraction according with a standard protocol ^11^.

2.  Extract DNA also from semen collected from roosters, and from unfertile oocytes (\< 5 mm) collected from hens hatched from eggs inoculated with *T. cruzi*, and from hens hatched from control eggs ^3,\ 4^.

3.  Extract kDNA from the *T. cruzi* epimastigote forms and, also, from *Lb* promastigotes, as described elsewhere ^9^.

4. Primers and Probes Used
--------------------------

The primers used for PCR amplifications and the thermal conditions are shown in **Table 1**.

The probes used in Southern blot hybridizations were:

1.  Wild-type minicircle (\~1.4 kb) sequences purified from *T. cruzi* epimastigote forms;

2.  Minicircle fragments (362 bp) obtained by *Nsi*I digests of wild-type kDNA;

3.  Nuclear DNA (nDNA) repetitive sequence (188 bp) obtained by amplification of the parasite DNA with the Tcz1/2 primers. The probes were purified from 1% agarose gels ^3^.

4.  Wild-type minicircle (\~0.820 kb) sequences from *Lb* promastigotes.

5. PCR Analyses
---------------

1.  Run standard PCR procedure with genomic DNAs from infected chicks and uninfected controls and mock using *T. cruzi* nDNA Tcz1/2 ^12^ and kDNA s35/s36 ^13^ primers. Also, run PCR with genomic DNAs from chickens hatched from *Lb* infected-eggs using the protozoan specific Lb3 and Lb5 primers (**Table 1**).

2.  Make reaction mix with 100 ng template DNA, 0.4 μM of each pair of primers, 2 U Taq DNA polymerase, 0.2 mM dNTP, and 1.5 mM MgCl~2~ in a 25 μL final volume.

3.  Set thermocycler program for 95 °C for 5 min, 30 cycles of 30 sec at 95 °C/30 sec at 68 °C/1 min at 72 °C with 5 min final extension before refrigeration.

4.  Analyze the amplification products in 1.3% agarose gel, which is transferred to a positively-charged nylon membrane (GE Life Sciences) by the alkaline method for hybridization with specific probes labeled with \[α-~32~P\] dATP using Random Primer Labeling Kit (Invitrogen, Carlsbad, CA).

6. Genomic Southern Blots
-------------------------

1.  Use *Mbo*I and/or with *Eco*RI (Invitrogen) enzymes that make single cuts in minicircles integrated into DNA samples of body tissues.

2.  Digest DNA from uninfected control chickens and from chickens hatched from eggs inoculated with virulent *T. cruzi* forms.

3.  Subject the digests of DNA from *T. cruzi* and from chicken test samples to electrophoresis in 0.8% agarose gel at 50 V overnight at 4 °C.

4.  Transfer separated DNA bands to positively charged nylon membrane.

5.  Hybridize the DNA bands with radio labeled kDNA probe.

6.  Wash the membrane twice for 15 min at 65 °C with 2X SSC and 0.1% SDS, twice for 15 min at 65 °C each with 0.2X SSC and 0.1% SDS, and autoradiograph for variable periods of time.

7. Targeted Prime TAIL-PCR
--------------------------

1.  Obtain amplification of the kDNA minicircle integrated into the chicken genome by a modified TAIL-PCR technique, which combines kDNA primers with specific primer sets ^2^ in three walk-in cycles nested PCR, as shown in **Figure 1**.

2.  Primary cycle: Each reaction includes 200 ng template DNA, 2.5 mM MgCl~2~, and 0.4 μM of kDNA primers (S34 or S67), 0.2 mM dNTPs, 2.5 U Taq Platinum (Invitrogen, Carlsbad, CA). Use the kDNA primers in combination with 0.04 μM of Gg primers (*Gg1* to *Gg6*, **Table 1**), separately. Set temperatures from 57.9 to 60.1 °C for kDNA primers and from 59.9 to 65.6 °C for CR-1 primer. Note that these temperatures are higher than those (\~45 °C) required for the arbitrary degenerated primers used in the TAIL-PCR ^10^. Use temperature and cycles (MyCycle Thermocycler, Bio-Rad Laboratories, Hercules, CA) described in a previous paper ^3^.

3.  Secondary cycle: Dilute PCR products from primary cycle 1:40 (v/v) in water. kDNA primers S35 and S35 antisense replaced the previous ones, along with the same *Gg* primers.

4.  Tertiary cycle: Dilute PCR products from secondary cycle 1:10 (v/v) in water and combine *Gg* primers with S67 antisense or S36, separately.

5.  Clone the PCR tertiary cycle products: Clone directly in pGEM T easy vector (Promega, Madison, WI) the products of last amplification that hybridize with kDNA probe.

6.  Select clones by hybridization with kDNA probe and sequence.

7.  Validate the tpTAIL-PCR in a mix of 300 pg of kDNA from *T. cruzi* with 200 ng of DNA from control birds never exposed to kDNA. The temperature and amplification cycles are the same used for the test birds\' DNA.

8. Chagas Disease Clinic Manifestation
--------------------------------------

1.  Monitor growth and development of chickens hatched from *T. cruzi* infected eggs and of healthy controls hatched from non-infected eggs daily for mortality and weekly for disease manifestations.

2.  Detect clinical abnormalities in those chickens (**Figure 2**) and make electrocardiograph (ECG) recordings to evaluate the electrical axes, heart rates and arrhythmias ^3^.

3.  Subject kDNA-mutated and controls chickens monthly to ECG recordings of augmented ventricular unipolar leads aVF (left leg), aVL (left arm), and aVR (right arm), and to assess deviation of mean electrical axis to the left, which is suggestive of heart enlargement ^3^.

9. Pathology and Immunochemical Analyses
----------------------------------------

1.  Record heart and body weight indexes after natural deaths of kDNA mutated chickens (**Figure 3**). Obtain indexes also for control chickens of the same age and gender.

2.  Take sections from the heart, esophagus, intestines, skeletal muscle, lungs, liver, and kidneys.

3.  Fix tissue in buffered 10% formalin (pH 7.4), embed in paraffin and cut to 4 μm thick sections for Hematoxylin-Eosin (HE) staining and histological analyses (**Figure 3**).

4.  Harvest and bisect tissues from embryos hatched from eggs inoculated with parasites expressing β-galactosidase, and subject to X-Gal-stain.^9^

5.  Fix the other half of the embryo tissues in 10% formalin, pH 7.4 and proceed as in step 9.3.

6.  Cut 4μm thin paraffin embedded tissue section and mount on glass slide for microscopic examination.

7.  Incubate sections showing X-Gal-stained blue cells with human chagasic antiserum (1:1024 dilution) against anti-*T. cruzi* antigen.

8.  Wash sections trice with PBS, pH 7.4, 5 min each.

9.  Stain blue cells in the embryo tissues by second incubation with a fluorescein-conjugated rabbit anti-human IgG.

10. Wash sections with PBS (step 8), mount with coverslip and observe the blue cells light-up green upon examination under UV light at 502 nm wavelength, 200x magnification, for colocalizing *T. cruzi* in embryo cells.

10. Phenotype Immune System Cells in Heart Lesions
--------------------------------------------------

1.  Phenotype immune effectors cells in tissue sections of heart from kDNA-positive and from control kDNA-negative chickens.

2.  Place the slides with tissue section embedded in paraffin at 65 °C for 30 min to melt wax previous to submission in four washes in 100% to 70% xylene and then in absolute ethanol PBS for 5 min each.

3.  Rinse the slides in distilled water, air dry, and treat with specific monoclonal antibodies (fluorescein- or R-phycoerythrin-conjugated monoclonal antibodies) obtained from SouthernBiotech, Birmingham, AL. Use mouse anti-chicken Bu-1 (Bu-1~a~ and Bu-1~b~ alleles, Mr 70-75 kDa) Mab AV20 to recognize monomorphic determinant on the B cell antigens of inbred chickens.Use mouse anti-chicken CD45, Ig isotype IgM1 κ specific to chicken thymus lineage cells (Mr 190 to 215-KDa variant).Use mouse anti-chicken TCRγδ+ (Mr 90-kDa heterodimer) Mab specific to thymus dependent CD8α+T cells.Use mouse anti-chicken Mab CD-8 specific to chicken α chain (Mr 34 kDa) recognize the CD8 cells in thymocytes, spleen, heart, and other tissues.Use mouse anti-chicken KuL01 to exclusively recognize monocytes/macrophages of the phagocyte system.

4.  Wash the slide three times with 0.1 M PBS, pH 7.4, 5 min each after incubation with specific anti-phenotype antibody for 90 min in a moist chamber.

5.  Assemble the slide with buffered glycerin for exam under a fluorescent light microscope with emission filter of wavelength 567 and 502 nm, respectively, to detect red and green fluorescence-labeled cells (**Figure 4**).

11. Data Analyses
-----------------

1.  Use the chicken genome database (<http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid=9031>) for BLASTn sequence analyses.

2.  Use CLUSTALW alignments to determine e-value scores.

3.  Employ the GIRI repeat masking algorithm CENSOR (<http://girinst.org/censor/index.php>) for localization of different classes of repeats in chimeric sequences.

4.  Employ the Kinetoplastid Insertion and Deletion Sequence Search Tool (KISS) to identify potential gRNAs in the kDNA sequences, with the aid of WU-Blastn-modified-matrix ^3^.

5.  Use *T. cruzi* sequences [http://www.biomedcentral.com/content/supplementary/1471- 2164-8-133-s1.fas](http://www.biomedcentral.com/content/supplementary/1471-2164-8-133-s1.fas) to search-in gRNAs in the kDNA-host DNA chimeras. 11.6) Use Student\'s t and the Kolmorov-Smirnov tests, respectively, to detect significant differences between deviations of electric axes and between heart/body weight indexes obtained in the experimental and control groups, and to detect mortality ratios significant differences between groups of chickens hatched from *T. cruzi* inoculated eggs and from controls.

12. Representative Results
--------------------------

The inoculation of 100 virulent *T. cruzi* trypomastigotes into the air chamber of fertile chicken eggs does not reduce significantly the ratios of chicks hatched alive. Approximately 60% hatch healthy chicks and 40% may undergo embryo liquefaction or embryo death at hatching. The surviving chicks retain the kDNA minicircle sequence integrated in the genome. However, it is expected that some chicks will die with cardiomegaly and failure in the weeks after hatching. The remaining chicks will grow to outwardly healthy adults. At all stages of life the DNA extracted from their blood mononuclear cells will yield PCR amplification of kDNA, but not nDNA. The targeted-prime TAIL-PCR ^3,\ 4^ products that are cloned and sequence will show the kDNA minicircles integrated mainly in coding regions of macrochromosomes 1 to 5. The chickens showing multiple kDNA integrations into genes coding for cell growth and differentiation, immune system regulation factors, and DNA repair are candidates to undergo rejection of self target tissues (**Figure 3**). For example, the chicken showing kDNA mutation with rupture of the dystrophin gene (**Figure 5**), coding a protein that binds the cytoskeleton to the cell membrane, is a candidate to develop autoimmune inflammatory cardiomyopathy and failure.

These genomic modifications are not seen in chicks hatched from *Lb* infected eggs. There are differences between *T. cruzi* and *Lb* kDNA minicircles; The *T. cruzi* k*DNA* minicircle average 1.4 kb structure with four variable region (VR) interspersed by conserved regions (CR) each presenting CSB1, CSB2, and CSB3 regions, in which CA-rich bent DNA are considered specific sites for initiation of replication, transcription, recombination, and for lateral DNA transfer ^3,\ 4^. Contrastingly, the *Lb* kDNA minicircle (average size 820 bp) contains single CR followed by VR. CR has conserved CSB1 (GGGCGT) and CSB2 (CCCCGTTC) blocks, which are different from those in the *T. cruzi* minicircles ^15,\ 16,\ and\ 17^. Considering that *Lb* CSB3 (GGGGTTGGTGTA) shows 12 nts homology to the *T. cruzi* it is conceivable that either the *Lb* kDNA minicircle integrates in a much low frequency, which may not be visible by the techniques used, or that it may, possibly, not integrate in the chicken genome at all.

  ------------ ----------------- ----------------------------------------------- ----------
  **Primer**   **Target DNA**    **Sequence**                                    **Tm\***
  S 34         *T. cruzi*kDNA    5\' ACA CCA ACC CCA ATC GAA CC 3\'              57.9
  S 67         *T. cruzi*kDNA    5\' GGT TTT GGG AGG GG(G/C) (G/C)(T/G)T C 3\'   60.1
  S 35         *T. cruzi*kDNA    5\' ATA ATG TAC GGG (T/G)GA GAT GC 3\'          59.4
  S 36         *T. cruzi*kDNA    5\' GGT TCG ATT GGG GTT GGT G 3\'               57,9
  *Lb3*        *Lb*kDNA          5\' GGG GTT GGT GTA ATA TAG TGG G 3\'           55.9
  *Lb5*        *Lb*kDNA          5\' CTA ATT GTG CAC GGG GAG G 3\'               61.4
  *Gg*1        *Gallus gallus*   5\' AGC TGA TCC TAA AGG CAG AGC 3\'             60.1
  *Gg2*        *G. gallus*       5\' CTG AGC CTC TGC TTT GAA A 3\'               56.8
  *Gg3*        *G. gallus*       5\' TTT CAA AGC AGA GGC TCG G 3\'               60.1
  *Gg4*        *G. gallus*       3\' GCT CTG CCT TTA GGA TCA GCT 5\'             64.2
  *Gg5*        *G. gallus*       3\' AGC AAC TCA GCG TCC ACC TT 5\'              62.3
  *Gg6*        *G. gallus*       3\' CTG TTA GCA TGA GGC TTC ACA A 5\'           60.4
  ------------ ----------------- ----------------------------------------------- ----------

**Table 1.** Primes Used in the PCR Amplifications. \* Tm = average annealing temperature °C.

**Figure 1.** The *tp*TAIL-PCR strategy used to detect *Trypanosoma cruzi* kDNA integration into the *Gallus gallus* genome. A) A chimeric sequence with a fragment of kDNA minicircle conserved (dark blue) and variable (light blue) regions integrated in the locus NW_001471687.1 at chromosome 4 (AY237306) of the chicken ^10^ genome (green) was used to obtain the host specific primer sets (*Gg1* to *Gg6*). B) The *tp*TAIL-PCR amplifications were initiated (primary cycle) by annealing of the minicircle-specific S34 or S67 primers in combination with the chicken-specific *Gg1* to *Gg6* primers. Diluted products provided template for the secondary cycle with the S35 (sense/antisense) primers and the combinations of *Gg* primers. In the tertiary cycle a dilution of the secondary products was subjected to amplification with kDNA S36 or S67 antisense primers in combination with the *Gg* primers. C) These amplification products were separated in 1% agarose gels and transferred to nylon membrane, hybridized with the specific kDNA probe. Samples showing positive signal were used for cloning to determine the point of integration. The combinations of kDNA and targeted *Gg1* to *Gg6* are shown on top of the gel. The sequential PCR reactions amplified target kDNA-host DNA sequences with kDNA minicircles (blue) and the avian sequence (green). (Reprinted from *PLoS Neglected Tropical Diseases*^3^). Please [click here](http://www.jove.com/files/ftp_upload/3716/3716fig1_lg.jpg) to see a larger version of this figure.

**Figure 2.** Clinical manifestations of impaired heart function in a 9-month-old chicken genetically modified by the integration of the mitochondrial kDNA minicircle from *T. cruzi*. The poor blood oxygenation of the mitochondrial kDNA mutated chicken showing a purple comb contrasts with the bright red comb of the control 9-month-old chicken free from heart damage. (Modified from *PLoS Neglected Tropical Diseases*^3^).

**Figure 3.** Gross and microscopic pathology in *Gallus gallus* with kDNA mutations. A) Cardiomegaly in a 9-month-old hen that died of heart failure. B) Control heart from a noninfected 9-month-old hen. C) Rejection of target heart cells by cytotoxic lymphocytes: A minimal rejection unit with lyses of the target cells by immune lymphocytes is depicted (circle). D) Control heart histology (Modified from *PLoS Neglected Tropical Diseases* ^3^ ).

**Figure 4.** Immunocytochemical analyses of the immune system cells infiltrating the heart of kDNA-mutated chicken shown in **Figure 3**. A) CD45+ lymphocytes identified (arrows) in heart lesions by a phycoerythrin-labeled specific monoclonal antibody. B) CD8+γδ immune lymphocytes (arrows) involved in severe destruction of the heart. C) Abundant CD8α+ T cells present in severe lesions with heart cell lyses. The inserts show the absence of immune system cells in the control uninfected chicken heart (Modified from *PLoS Neglected Tropical Diseases* ^3^ ).

**Figure 5.** Chagas-like dilated inflammatory cardiomyopathy in a F2 progeny with kDNA integration in the dystrophin gene. A) Dilated heart in a 10-month-old chicken occupying most of the thoracic cavity (heart weight = 16 g). B) Dark round mononuclear cells infiltrates and destroys the myocardium of the kDNA-mutated hen. C) Normal heart size (weight 7 g) of a 10-month-old control chicken. D) Normal histology of a control chicken heart. (Modified from *PLoS Neglected Tropical Diseases* ^3^).

**Figure 6.** Comparative pathology in kDNA-mutated chicken and in human Chagas disease. A) Severe myocarditis and target heart cell lyses in the kDNA-mutated chicken. B) Severe myocarditis and target cell lyses by immune lymphocytes in a case of Chagas heart disease. C) Rejection of heart cells by immune lymphocytes in the kDNA-mutated chicken. D) Rejection of heart cells by immune lymphocytes in human Chagas disease. Stained by Hematoxilin and Eosin. (Modified from *Memórias do Instituto Oswaldo Cruz*, Rio de Janeiro ^14^).

Discussion
==========

In contrast to mammals susceptible to life-long *T. cruzi* infections, chickens are refractory to *T. cruzi* infection. The major advantage of the chicken model system is the elimination of the infection early in the development of the embryonic immune system. Thus, the only parasite DNA remaining within the chicken body is integrated at several loci.

Use of the optimal quantity of virulent *T. cruzi* trypomastigotes to inoculate fertile egg is the critical step towards obtaining integration of the kDNA minicircles into the chicken embryo genome. The rate of live chicks hatching from eggs inoculated with 100 trypomastigotes is four-fold higher than that obtained with 500 parasites. Care should be taken to inoculate the parasites suspension in 10 μL of culture medium into the egg air chamber. There should be no leakage of egg white. Under optimal conditions, the intracellular parasitic infection takes place within a few hours after incubation and parasite multiplication inside the host cells proceeds for one week; thereafter the infection is eliminated by the innate immunity. The kDNA integration requires a living infection, and the inoculation of naked minicircles into early embryo chicken eggs does not result in integration. The kDNA-positive embryos and controls should be housed under controlled conditions at 37.5 °C and 65% humidity. The chicks are kept in cages for two weeks at 33 °C room temperature. Thereafter the chickens are kept in cages on suspended racks separated by 1.5 meter width aisles in a room at 22 °C with filtered air and positive pressure under constant exhaustion to secure animal welfare conditions. The adults are fed chicken-chow and drink potable running water to achieve full growth and maturity, laying eggs at five months of age. Maintenance of hygienic procedures are essential for reproducibility of results when working with *T. cruzi* inoculated into fertile chicken eggs.

In the chicken model system the *T. cruzi* infections are eradicated after development of the immune system in the early period of embryo growth. Additionally to being infection-free, the chicks that hatch from *T. cruzi* inoculated eggs, in lack of specific antibodies, are tolerant to the parasite antigens. The rejection of the target heart cells by cytotoxic lymphocytes (minimal rejection unit, **Figure 3**) is seen in the kDNA-mutated chickens showing genotype modifications and breakdown of immunological surveillance ^3^. The genotypically modified T-cells present accelerated rejection of self tissues in the body. The main lesion site is the heart, which is a hallmark of Chagas disease. The passage from a physiologic (surveillance) to a physiopathologic state is seen in the kDNA-mutated chicken showing clonally proliferation of cytotoxic lymphocytes ^3^.

This transkingdom model system shows a parasite-induced, genetically-driven autoimmune disease (**Figure 6**), stemming from genome modifications by the *T. cruzi* kDNA minicircle integrations. These modifications are not seen in chicks hatched from *Lb*-inoculated eggs.

This phenomenon suggests that experimental treatment of the inflammatory autoimmune cardiomyopathy in kDNA-mutated chickens may require drug suppression of bone marrow progenitor of specific T-cell phenotype infiltrating the myocardium, and transplantation of histocompatible healthy bone marrow to prevent the rejection of self-tissue.
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